NCT07394374 2026-02-06A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene AbnormalitiesCullgen (Shanghai),IncPhase 1/2 Recruiting42 enrolled